Orion Oyj : Orion has submitted a marketing authorisation application for combined budesonide-formoterol formulation of the

  Orion Oyj : Orion has submitted a marketing authorisation application for
 combined budesonide-formoterol formulation of the Easyhaler® product family

ORION CORPORATION    STOCK EXCHANGE RELEASE 21 MARCH 2013 at 6.25
p.m.EET


Orion Corporation has submitted a marketing authorisation application for
combined budesonide-formoterol formulation of the Easyhaler® product family in
Europe. Orion applies for approval in European Union through decentralised
procedure. The review process will commence once all involved member states
have validated the application.


Orion Corporation

Timo Lappalainen   Reijo Salonen
President and CEO  SVP, Research and Development

           
  

Contact person:
Reijo Salonen, SVP, Research and Development, phone +358 50 966 3647

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. Pharmaceutical R&D focuses on central nervous
system drugs, oncology and critical care drugs, and Easyhaler® pulmonary
drugs.

Orion's net sales in 2012 amounted to EUR 980 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX
Helsinki.

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Orion Oyj via Thomson Reuters ONE
HUG#1687256
 
Press spacebar to pause and continue. Press esc to stop.